The company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg has been granted tentative approval by the USFDA.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2DHXt9Q
via IFTTT
0 comments:
Post a Comment